Evaluation reports are either openly accessible via pdf download, or accessible via MSF's internal Sharepoint, which is mainly due to the sensitive nature of the operational contexts and resulting content. However, there are ongoing discussions about making all evaluation reports publicly searchable. If you are an MSF association member, reports are made available on various associate platforms such as

- Revue du Projet d’assistance aux réfugiés de RDC, Betou, Congo Bza: a été réalisée en cours de projet et permet de ré-orienter les objectifs/ priorités sanitaires, et de préciser le cadre de l’évolution par rapport à des sujets majeurs (HIV/Sida, Lèpre, TB, PEV, Surveillance, etc).


MSF-OCA has been addressing a highly relevant issue, TB and DR-TB in Uzbekistan. A steady decrease of the notification and the mortality rates has been indicating a good outcome of the TB DOTS programme. MSF is highly appreciated by the MOH of Uzbekistan as one of the main partners in TB control and the first one who started the diagnosis and treatment of DR-TB. The current model of comprehensive TB care was estimated as the most appropriate approach for this low-income country with high TB/MDR-TB burden. It could be successfully expanded to elsewhere in the region.

Kai Blöndal and Oscar Bernal

The evaluation analysed MSF intervention strategies of the TB project in the Penal sector of Kyrgyzstan by reviewing relevance, effectiveness and continuity. It assessed current challenges and shortcomings of the intervention in order to recommend new techniques and approaches for the year 2011 and beyond.

Gill Bradbury, Walli Wernhart, and Dr. A.Jamil Faqirzai

In May 2007 MSF-OCA integrated the drug-resistant tuberculosis (DR-TB) treatment programme into the horizontal primary and secondary health care programme at Shabunda, located in South Kivu District of Democratic Republic of Congo (DRC). The three patients were started on the DR-TB treatment on 17th May 2007. MSF closed the project by the end of 2007, but continued taking responsibility for the treatment of the three DR-TB patients through remote supervision by providing medical, laboratory and social support.